22-50224426-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_020461.4(TUBGCP6):c.2066-6A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000657 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020461.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBGCP6 | NM_020461.4 | c.2066-6A>G | splice_region_variant, intron_variant | Intron 11 of 24 | ENST00000248846.10 | NP_065194.3 | ||
TUBGCP6 | XR_001755343.3 | n.2630-6A>G | splice_region_variant, intron_variant | Intron 11 of 19 | ||||
TUBGCP6 | XR_007067982.1 | n.2630-6A>G | splice_region_variant, intron_variant | Intron 11 of 18 | ||||
TUBGCP6 | XR_938347.3 | n.2630-6A>G | splice_region_variant, intron_variant | Intron 11 of 22 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000676 AC: 17AN: 251494Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135920
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 38AN XY: 727236
GnomAD4 genome AF: 0.000112 AC: 17AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74338
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
Observed with a second TUBGCP6 variant, phase unknown, in two siblings with familial exudative vitreoretinopathy and microcephaly in published literature (PMID: 31077665); Published functional studies demonstrate a damaging effect secondary to a truncated protein (PMID: 31077665); Not observed at significant frequency in large population cohorts (gnomAD); Located in a region that tolerates variation and lacks pathogenic variants; This variant is associated with the following publications: (PMID: 36307859, 37229200, 33458610, 37031378, 31077665) -
This sequence change falls in intron 11 of the TUBGCP6 gene. It does not directly change the encoded amino acid sequence of the TUBGCP6 protein. This variant is present in population databases (rs368765755, gnomAD 0.01%). This variant has been observed in individual(s) with clinical features of microcephaly and chorioretinopathy (PMID: 31077665, 36307859, 37031378). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 437169). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Microcephaly and chorioretinopathy 1 Pathogenic:1Uncertain:1
- -
The TUBGCP c.2066-6A>G variant occurs in a splice region. This variant has been reported in individuals with clinical features consistent with microcephaly and chorioretinopathy, including in one individual in whom it was confirmed in trans with a likely pathogenic variant in the gene. The c.2066-6A>G variant was shown to segregate with disease in one family in two siblings (PMID: 31077665; 37031378). The highest frequency of this variant in the Genome Aggregation Database is 0.000241 in the African/African American population (version 3.1.2). Functional studies demonstrated that the c.2066-6A>G variant results in the insertion of five intronic nucleotides, which is predicted to lead to a frameshift in the protein reading frame and premature termination of the protein (PMID: 31077665). The c.2066-6A>G variant was identified in trans with a likely pathogenic variant. Based on the available evidence, the c.2066-6A>G variant is classified as likely pathogenic for microcephaly and chorioretinopathy. -
not specified Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at